Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Ling Lin

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Ebiomedicine|November 28, 2021
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitroHsiang-Chi Huang, Yun-Ju Lai, Chun-Che Liao, et al.
Emerging Microbes & Infections|November 17, 2022
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concernI-Jung Lee, Yu-Hua Lan, Ping-Yi Wu, et al.
Head and Neck Pathology|May 13, 2021
Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 CasesJustin A Bishop, Dipti P Sajed, Ilan Weinreb, et al.
JCI Insight|May 22, 2024
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibodyYi-Hsuan Chang, Min-Feng Hsu, Wei-Nan Chen, et al.
Journal of Medical Virology|January 7, 2023
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasionHsiang-Chi Huang, Shih-Han Wang, Guo-Chen Fang, et al.
Vaccines|February 26, 2022
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in TaiwanJer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, et al.
The Journal of Clinical Investigation|November 1, 2021
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2Wan-Chen Hsieh, En-Yu Lai, Yu-Ting Liu, et al.
Cell Reports|September 5, 2024
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neuronsChing Ying Huang, Martin W Nicholson, Jyun Yuan Wang, et al.
Cell Reports|April 6, 2022
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neuronsChing Ying Huang, Martin W Nicholson, Jyun Yuan Wang, et al.
Plos Pathogens|October 21, 2021
Structure-guided antibody cocktail for prevention and treatment of COVID-19Shih-Chieh Su, Tzu-Jing Yang, Pei-Yu Yu, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Ebiomedicine|November 28, 2021
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitroHsiang-Chi Huang, Yun-Ju Lai, Chun-Che Liao, et al.
Emerging Microbes & Infections|November 17, 2022
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concernI-Jung Lee, Yu-Hua Lan, Ping-Yi Wu, et al.
Head and Neck Pathology|May 13, 2021
Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 CasesJustin A Bishop, Dipti P Sajed, Ilan Weinreb, et al.
JCI Insight|May 22, 2024
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibodyYi-Hsuan Chang, Min-Feng Hsu, Wei-Nan Chen, et al.
Journal of Medical Virology|January 7, 2023
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasionHsiang-Chi Huang, Shih-Han Wang, Guo-Chen Fang, et al.
Vaccines|February 26, 2022
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in TaiwanJer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, et al.
The Journal of Clinical Investigation|November 1, 2021
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2Wan-Chen Hsieh, En-Yu Lai, Yu-Ting Liu, et al.
Cell Reports|September 5, 2024
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neuronsChing Ying Huang, Martin W Nicholson, Jyun Yuan Wang, et al.
Cell Reports|April 6, 2022
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neuronsChing Ying Huang, Martin W Nicholson, Jyun Yuan Wang, et al.
Plos Pathogens|October 21, 2021
Structure-guided antibody cocktail for prevention and treatment of COVID-19Shih-Chieh Su, Tzu-Jing Yang, Pei-Yu Yu, et al.
Pageof 30